Ignite Creation Date:
2024-05-06 @ 7:54 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178211
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-20
First Post:
2023-11-18
Brief Title:
Neoadjuvant Adebrelimab Plus Chemotherapy for Resectable ESCC a Single Arm Prospective Phase 2 Clinical Trial
Sponsor:
Organization:
Shanghai Chest Hospital